Median tacrolimus and sirolimus levels during the first 30 days after HCT
| . | Median tacrolimus level, ng/mL (IQR) . | P . | Median sirolimus level, ng/mL (IQR) . | P . |
|---|---|---|---|---|
| Flu/Mel (n = 46) | 8.65 (6.90, 9.90)* | .003 | 7.25 (5.80, 8.70) | .916 |
| TBI/VP16 (n = 28) | 9.45 (8.20, 10.55)* | 7.00 (5.45, 9.35) | ||
| Bu/Cy (n = 11) | 10.40 (9.20, 10.99)* | 6.90 (6.20, 8.90) |
| . | Median tacrolimus level, ng/mL (IQR) . | P . | Median sirolimus level, ng/mL (IQR) . | P . |
|---|---|---|---|---|
| Flu/Mel (n = 46) | 8.65 (6.90, 9.90)* | .003 | 7.25 (5.80, 8.70) | .916 |
| TBI/VP16 (n = 28) | 9.45 (8.20, 10.55)* | 7.00 (5.45, 9.35) | ||
| Bu/Cy (n = 11) | 10.40 (9.20, 10.99)* | 6.90 (6.20, 8.90) |
HCT indicates hematopoietic cell transplantation; and IQR, interquartile range.
P < .01.